Brand dynamics
Group Real-Time Dynamics And Cutting-Edge Information In The Field Of One Health
Intellectual Property Protection Supports Bay Area Innovation: Healthy Yuan Awarded "2019 National Intellectual Property Demonstration Enterprise"
Published Time：
2019-12-06
Recently, the State Intellectual Property Office of China (SIPO) released the "2019 National Intellectual Property Advantage Demonstration Enterprise Review and Re-examination Results Announcement." Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Health Yuan Pharmaceutical Group"), with its excellent independent innovation capabilities and sound intellectual property management system, passed the strict review of the expert group and successfully won the highest honor awarded by the state for outstanding work in the creation, application, protection, and management of intellectual property rights by enterprises—the "2019 National Intellectual Property Demonstration Enterprise." It is reported that among the 274 national intellectual property demonstration enterprises selected this time, only 4 were recommended by the Shenzhen Intellectual Property Office, namely Health Yuan Pharmaceutical Group, DJI Innovation, Hanyu Pharmaceutical, and China Construction Steel Structure, all of which are industry leaders. It is worth mentioning that Shenzhen Haibin Pharmaceutical Co., Ltd., a subsidiary of Health Yuan Pharmaceutical Group, was also awarded the "National Intellectual Property Advantage Enterprise," winning both important honors. This is another achievement of Health Yuan Pharmaceutical Group's consistent emphasis on independent technological research and development and the in-depth implementation of its intellectual property strategy.
(Image source: SIPO official website)
It is reported that in order to implement the "National Intellectual Property Strategy Outline" and the "National Patent Development Strategy (2011-2020)", and to accelerate the formation of a group of backbone enterprises with independent intellectual property rights, well-known brands, and strong international competitiveness, according to the requirements of the "Notice on Carrying Out the Cultivation of National-level Intellectual Property Advantage Enterprises and Demonstration Enterprises" (Guo Zhi Fa Guan Zi [2013] No. 36), the State Intellectual Property Office has been evaluating national intellectual property demonstration enterprises since 2013. This honor is not only the highest honor awarded by the state for outstanding work in the creation, application, protection, and management of intellectual property rights by enterprises, but also the highest evaluation given by the state to the enterprise's intellectual property management work. The enterprises that have passed the review, as leaders in regional intellectual property development, will provide strong support for intellectual property development.
(Image source: SIPO official website)
Over the years, Health Yuan Pharmaceutical Group has adhered to and implemented the "Enterprise Intellectual Property Management Standards," establishing a solid and comprehensive intellectual property management system and attaching great importance to the research and development and innovation of pharmaceutical technologies. It has obtained numerous intellectual property rights. At the same time, relying on its strength and experience in the greater health field, the company continues to develop pharmaceutical technologies with independent intellectual property rights. It has developed from a well-known health product company into a large health pharmaceutical group with strong comprehensive strength in China, and its business covers many sectors, including chemical preparations, raw materials, traditional Chinese medicine, health products, OTC, and diagnostic reagents.
Health Yuan Pharmaceutical Group and Shenzhen Haibin Pharmaceutical Co., Ltd.'s winning of the "2019 National Intellectual Property Demonstration Enterprise" and "National Intellectual Property Advantage Enterprise" respectively is the best affirmation by authoritative institutions of the group's independent R&D capabilities, intellectual property protection capabilities, and future market development potential. It also marks a new stage for Health Yuan Pharmaceutical Group in intellectual property construction and management. The group's relevant leaders stated that in the future, the company will continue to increase investment in scientific research, focus on core technology research and development, improve relevant intellectual property protection mechanisms, and strengthen the transformation of scientific research results. While consolidating and enhancing its own core competitive advantages, it will also promote the innovative development of the Guangdong-Hong Kong-Macao Greater Bay Area.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.